Steven Nathan on Big Pharma: Aspen and Ascendis

Loading player...
10X founder Steven Nathan shares his pearls of wisdom on interesting developments taking place across local and international markets. Since his departure at 10X at the beginning of the year, Nathan has been on ‘garden leave’, which is a restraint of trade prohibiting him from working in the asset management industry for two years. Despite calling his time off “refreshing”, Nathan says it’s important to not lose focus and hence has been keeping up to date with all the market trends in 2021. Local talking points include Northam Platinum’s R17bn deal with Royal Bafokeng Platinum; representative of the Ascendis Activist Investors (Harry Smit) being appointed to the board of directors; and Mark Sardi departing the debt-laden pharma business for South Africa’s pharma leader, Aspen. Learn more about your ad choices. Visit megaphone.fm/adchoices
10 Nov 2021 8AM English South Africa Investing · Business News

Other recent episodes

To study or to start a business? The choice that built Bubbadue

More than one in 10 university graduates in South Africa cannot find a job. With an economy that creates far too few jobs for the people entering it, and AI starting to eat into white-collar work, many school leavers and their parents are asking whether a degree is still the…
20 Nov 5AM 14 min

BN Edge | Michael Beaumont on ActionSA's coalition hand and the DA standoff

Michael Beaumont has been called the power behind ActionSA's throne, and he's the man running its coalition talks across Gauteng. Speaking to Alec Hogg hours before ActionSA's first sit-down with the DA, he said the DA had never once come to the table until then, and that his party had…
19 Nov 9AM 50 min